Objective
The opportunity to focus on the production of biopharmaceuticals is often taken from SMEs since huge amount of resources is required for the development of high-producer cell lines. We envision that our parental cell factories will increase the efficiency of cell line engineering and will effectively reduce the time-to-market for mammalian cell-based products. It allows SMEs to leverage their traditional strengths of adaptability and creativity, and to develop novel products for biotechnology industries.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
ICOSAGEN CELL FACTORY OU
Net EU contribution
€ 50 000,00
Address
EERIKA TEE 1
61713 Kambja Vald
Estonia
61713 Kambja Vald
Estonia
SME
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Yes
Region
Eesti
Eesti
Lõuna-Eesti
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00